Olmesartan (Benicar®) belongs to the class of medicines called angiotensin II receptor antagonists to treat high blood pressure. It is marketed by Sankyo Pharma, Inc. Olmesartan works by blocking the action of angiotension II. As a result of this blockage, olmesartan restricts vasoconstriction and the secretion of aldosterone. This lowers blood pressure by producing vasodilation, and decreasing peripheral resistance.

Administration

---

Olmesartan is available in 5, 20, and 40 mg tablets. A normal dose for an adult (including the elderly and mild renal or hepatic impairment) is 20 mg/day in one dosage. This may be increased after two weeks to 40 mg/day if further blood pressure reduction is needed.

Side effects

---

Side effects include:

• Dizziness
• Headache
• Diarrhea
• Upper respiratory tract infection

More on [ Olmesartan ]

Olmesartan Medoxomil - Twitter Search

Cardio: An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertension: Journal of the Americ http://url4.eu/vcFq
MDLinx (Sandeep Pulim MD) Mon, 14 Dec 2009 09:51:21 -0000
Cardio: An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertension: Journal of the Americ http://url4.eu/vcFq
safety & tolerability of tak-491 + chlorthalidone compared 2 olmesartan medoxomil-hydrochlorothiazide in ppl w/ http://bit.ly/71A5WP
paidtrials (US Clinical Trials) Sat, 12 Dec 2009 12:22:50 -0000
safety & tolerability of tak-491 + chlorthalidone compared 2 olmesartan medoxomil-hydrochlorothiazide in ppl w/ http://bit.ly/71A5WP

Subscribe to Olmesartan_Medoxomil RSS feed